{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:38:58Z","timestamp":1778182738951,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.anndiagpath.2021.151720","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T12:15:09Z","timestamp":1612959309000},"page":"151720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature"],"prefix":"10.1016","volume":"52","author":[{"given":"Mehrnoosh","family":"Tashakori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beenu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151720_bb0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrc.2017.127","article-title":"From genetics to the clinic: a translational perspective on follicular lymphoma","volume":"18","author":"Huet","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151720_bb0010","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.anndiagpath.2021.151720_bb0015","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","article-title":"Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone","volume":"111","author":"Feldman","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151720_bb0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12185-009-0300-y","article-title":"Histiocytic\/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature","volume":"89","author":"Zhang","year":"2009","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151720_bb0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13000-018-0758-0","article-title":"KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma","volume":"13","author":"Choi","year":"2018","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151720_bb0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00428-019-02691-w","article-title":"Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature","volume":"476","author":"Pericart","year":"2020","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.anndiagpath.2021.151720_bb0035","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/PAS.0b013e318283099f","article-title":"Clonally related follicular lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation","volume":"37","author":"West","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151720_bb0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.anndiagpath.2021.151720_bb0045","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1172\/JCI72415","article-title":"Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression","volume":"124","author":"Sungalee","year":"2014","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.anndiagpath.2021.151720_bb0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10024-004-3027-z","article-title":"Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders","volume":"7","author":"Chikwava","year":"2004","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151720_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.humpath.2015.12.029","article-title":"BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases","volume":"52","author":"Alayed","year":"2016","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151720_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0889-8588(05)70514-1","article-title":"Controversies and new approaches to treatment of Langerhans cell histiocytosis","volume":"12","author":"Arceci","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"issue":"11","key":"10.1016\/j.anndiagpath.2021.151720_bb0065","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151720_bb0070","doi-asserted-by":"crossref","first-page":"e33891","DOI":"10.1371\/journal.pone.0033891","article-title":"B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease","volume":"7","author":"Satoh","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.anndiagpath.2021.151720_bb0075","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151720_bb0080","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.hoc.2015.06.004","article-title":"Genomic alterations in Langerhans cell histiocytosis","volume":"29","author":"Rollins","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9","key":"10.1016\/j.anndiagpath.2021.151720_bb0085","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-cell histiocytosis","volume":"379","author":"Allen","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2021.151720_bb0090","article-title":"MAP-kinase-driven hematopoietic neoplasms: a decade of progress in the molecular age","author":"Chakraborty","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"10.1016\/j.anndiagpath.2021.151720_bb0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/pin.12722","article-title":"Synchronous case of follicular lymphoma and Langerhans cell sarcoma in the same lymph node","volume":"68","author":"Shimono","year":"2018","journal-title":"Pathol Int"},{"issue":"3","key":"10.1016\/j.anndiagpath.2021.151720_bb0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/PAS.0b013e3182098799","volume":"35","author":"Wang","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"48","key":"10.1016\/j.anndiagpath.2021.151720_bb0105","doi-asserted-by":"crossref","first-page":"78355","DOI":"10.18632\/oncotarget.13058","article-title":"High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"issue":"5578","key":"10.1016\/j.anndiagpath.2021.151720_bb0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.1067518","article-title":"Reversion of B cell commitment upon loss of Pax5 expression","volume":"297","author":"Mikkola","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.anndiagpath.2021.151720_bb0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0092-8674(04)00419-2","article-title":"Stepwise reprogramming of B cells into macrophages","volume":"117","author":"Xie","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.anndiagpath.2021.151720_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood.2019001438","article-title":"Coactivation of NF-kappaB and notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion","volume":"135","author":"Xiu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2021.151720_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/2632010X19878410","article-title":"Combined tumors in hematolymphoid neoplasms: case series of histiocytic and Langerhans cell sarcomas arising from low-grade B-cell lymphoma","volume":"12","author":"Skala","year":"2019","journal-title":"Clin Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151720_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jcp.2003.015537","article-title":"Langerhans cell histiocytosis in sequential discordant lymphoma","volume":"58","author":"Adu-Poku","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151720_bb0135","article-title":"Langerhans Cell Sarcoma After Follicular Lymphoma: Evidence of Transdifferentiation. The College of American Pathologists 2020 annual meeting (CAP20 virtual)","author":"Ricks","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151720_bb0140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/DAD.0000000000001072","article-title":"Langerhans cell histiocytosis associated with underlying hematolymphoid disorders in adults: report of 2 cases and review of the literature","volume":"40","author":"Kiavash","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151720_bb0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00277-008-0459-y","article-title":"Langerhans cell histiocytosis mimicking relapse in a patient with follicular lymphoma","volume":"87","author":"Gimeno","year":"2008","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151720_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/PAS.0000000000001617","article-title":"Mayo Clinic Histiocytosis Working Group. Rosai-Dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2","volume":"45","author":"Ravindran","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2021.151720_bb0155","first-page":"3627","article-title":"Induction of cyclin D1 overexpression by activated ras","volume":"9","author":"Filmus","year":"1994","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.anndiagpath.2021.151720_bb0160","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","article-title":"The MEK\/ERK cascade: from signaling specificity to diverse functions","volume":"1773","author":"Shaul","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"34","key":"10.1016\/j.anndiagpath.2021.151720_bb0165","doi-asserted-by":"crossref","first-page":"20608","DOI":"10.1074\/jbc.271.34.20608","article-title":"Cyclin D1 expression is regulated positively by the p42\/p44MAPK and negatively by the p38\/HOGMAPK pathway","volume":"271","author":"Lavoie","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.anndiagpath.2021.151720_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4615-5873-6_5","article-title":"A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry","volume":"2","author":"Lavoie","year":"1996","journal-title":"Prog Cell Cycle Res"},{"issue":"20","key":"10.1016\/j.anndiagpath.2021.151720_bb0175","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1038\/sj.onc.1202647","article-title":"Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells","volume":"18","author":"Balmanno","year":"1999","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.anndiagpath.2021.151720_bb0180","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000000897","article-title":"Cyclin D1 is expressed in neoplastic cells of Langerhans cell histiocytosis but not reactive Langerhans Cell proliferations","volume":"41","author":"Shanmugam","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2021.151720_bb0185","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hon.2344","article-title":"BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children","volume":"35","author":"Zeng","year":"2017","journal-title":"Hematol Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:22Z","timestamp":1761078742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":37,"alternative-id":["S1092913421000204"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151720","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151720"}}